| Lauren N Hollier, MS, CCC-SLP | |
|
619 N Main St, Jennings, LA 70546-5347 | |
| (337) 824-8287 | |
| Not Available |
| Full Name | Lauren N Hollier |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 619 N Main St, Jennings, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265086847 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7632 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren N Hollier, MS, CCC-SLP 2002 Johnson St Ste 100, Jennings, LA 70546-3640 Ph: (337) 824-4547 | Lauren N Hollier, MS, CCC-SLP 619 N Main St, Jennings, LA 70546-5347 Ph: (337) 824-8287 |
News Archive
Consumers decide whether to use mail-in genetic tests based on both rational and emotional reasons, a finding that adds to a growing body of health-care behavior research on information seeking and avoidance, according to researchers at the University of California, Riverside.
The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.
For many years, DNA and proteins have been viewed as the real movers and shakers in genomic studies, with RNA seen as little more than a messenger that shuttles information between the two.
Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.
› Verified 3 days ago
Lauren Johnson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 Johnson St, Suite 100, Jennings, LA 70546 Phone: 337-824-4547 Fax: 337-824-4548 | |
Jenna Penton, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2002 Johnson St Ste 100, Jennings, LA 70546 Phone: 337-824-4547 Fax: 337-824-4548 | |
Madelyn Lanza, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 Johnson St Ste 100, Jennings, LA 70546 Phone: 337-824-4547 Fax: 337-824-4548 | |
Alison Moody, M. S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 619 N Main St, Jennings, LA 70546 Phone: 337-824-8287 | |
Kelly W. Robertson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4228 Grand Marais Rd, Jennings, LA 70546 Phone: 337-288-9418 | |
Miss Magen B Voiselle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 Johnson St, Ste. 100, Jennings, LA 70546 Phone: 337-824-4547 Fax: 337-824-4548 | |
Dona L Dietlein, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 Johnson St, Suite 100, Jennings, LA 70546 Phone: 337-824-4547 Fax: 337-824-4548 |